YOLFTbeta
Andon Health Co Ltd

Andon Health Co Ltd

002432 · SHE · Healthcare / Medical Instruments & Supplies

55.42CNY-1.50 (-2.64%)

Price History

Full chart

Market Stats

Previous Close56.92
Open57.32
Day Range54.97 – 57.70
52-Week Range36.91 – 92.93
Volume16.64M
Market Cap28.15B
P/E (TTM)5.78
Forward P/E82.64
EPS10.44
Dividend Yield2.73%
Beta-0.62
50-Day Avg67.72
200-Day Avg62.45

About

Andon Health Co., Ltd. engages in the research and development, production, and sales of health electronics and smart hardware products in China and internationally. It offers D-Itch stick insect bite healer, pulse oximeter, TENS, massager, bodyfat scale, pregnancy rapid test, blood pressure monitor, thermometer, red light allergy reliever, nasal irrigator, nebulizer, and blood glucose meter. Andon Health Co., Ltd. was founded in 1995 and is based in Tianjin, China.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Yi Liu
  • Employees1.25K
  • HeadquartersNo. 3 Jinping Street, Tianjin, China, 300190, China
  • Websitehttps://www.jiuan.com

Leadership

  • Mr. Yi LiuGM & Chairman · b. 1967
  • Mr. Yong WangDeputy GM & Director · b. 1978
  • Mr. Ming CongDeputy GM & Employee Director · b. 1983
  • Mr. Tong WuBoard Secretary · b. 1983
  • Fei QinHead of Accounting Department

Financials

Income Statement

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue216.94M279.51M313.16M298.70M351.84M356.08M407.57M425.45M397.86M420.14M597.92M563.88M706.28M2.01B2.40B26.32B3.23B2.59B1.37B
Growth (%)-+28.84%+12.04%-4.62%+17.79%+1.20%+14.46%+4.39%-6.49%+5.60%+42.31%-5.69%+25.25%+184.36%+19.36%+997.80%-87.72%-19.77%-47.32%
Cost of Revenue139.02M194.96M207.70M196.93M235.94M237.33M274.70M292.62M295.56M284.36M417.70M403.77M532.49M906.60M884.82M5.53B1.28B784.96M493.97M
Gross Profit77.92M84.54M105.46M101.77M118.20M118.75M132.87M132.83M102.29M135.78M180.22M160.11M173.79M1.10B1.51B20.79B1.96B1.81B871.62M
Gross Margin35.92%30.25%33.68%34.07%33.59%33.35%32.60%31.22%25.71%32.32%30.14%28.39%24.61%54.86%63.09%78.99%60.54%69.72%63.83%
Operating Expense34.86M48.61M61.24M84.43M109.49M128.53M143.60M112.52M255.49M127.57M351.55M252.03M153.25M863.17M509.73M2.47B342.61M-302.56M1.17B
Operating Income43.06M35.93M44.22M17.34M8.71M-9.78M-10.73M20.31M-153.20M8.22M-171.32M-91.92M20.54M238.59M1.00B18.31B1.61B2.11B-296.54M
Operating Margin19.85%12.86%14.12%5.80%2.47%-2.75%-2.63%4.77%-38.51%1.96%-28.65%-16.30%2.91%11.88%41.82%69.59%49.94%81.39%-21.72%
EBITDA44.74M36.78M48.62M32.06M30.06M-2.28M-11.99M-62.95M-112.86M-103.36M-130.85M-77.69M-140.98M478.25M985.28M18.57B829.08M709.44M2.72B
EBITDA Margin20.62%13.16%15.53%10.73%8.54%-0.64%-2.94%-14.80%-28.37%-24.60%-21.88%-13.78%-19.96%23.81%41.10%70.58%25.66%27.37%198.83%
Net Income43.91M31.30M39.04M23.72M20.81M6.98M-9.17M10.20M-150.76M14.50M-165.86M12.69M66.45M242.33M908.64M16.03B1.25B1.67B2.27B
Net Income Margin20.24%11.20%12.47%7.94%5.91%1.96%-2.25%2.40%-37.89%3.45%-27.74%2.25%9.41%12.07%37.91%60.92%38.74%64.38%165.99%
R&D---8.29M9.66M8.12M32.61M9.14M43.65M41.47M94.06M68.86M80.03M78.31M66.73M246.36M278.46M269.22M323.57M
R&D as % of Total Revenue---2.77%2.74%2.28%8.00%2.15%10.97%9.87%15.73%12.21%11.33%3.90%2.78%0.94%8.62%10.39%23.69%
Interest Expense667.78K103.97K251.06K449.89K39.33K4.84K1.24M4.93M3.09M8.78M18.26M8.66M10.49M9.60M17.16M6.73M15.23M69.42M113.52M
Interest Expense % of Total Revenue0.31%0.04%0.08%0.15%0.01%0.00%0.30%1.16%0.78%2.09%3.05%1.54%1.49%0.48%0.72%0.03%0.47%2.68%8.31%

Balance Sheet

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets151.46M205.40M237.84M822.23M836.49M818.47M934.16M1.00B819.87M2.36B2.10B1.95B1.94B2.53B3.93B21.73B22.62B26.34B29.31B
Total Liabilities32.18M66.06M59.45M42.27M60.94M60.72M186.39M243.69M210.92M814.57M729.06M381.91M341.75M704.84M1.09B1.71B2.79B4.84B7.28B
Total Equity119.28M139.34M178.39M779.96M775.55M757.71M747.68M758.75M608.95M1.54B1.37B1.58B1.66B1.88B2.87B19.55B19.23B20.74B21.83B
Cash84.53M31.62M19.42M545.87M440.25M376.77M338.68M117.90M122.09M754.64M654.69M438.31M331.28M913.71M895.59M5.44B2.46B3.51B3.33B
Total Debt------96.58M102.72M49.31M446.77M70.00M222.51M197.54M344.40M242.93M289.82M1.51B2.63B-
Net Debt-84.53M-31.62M-19.42M-545.87M-440.25M-376.77M-242.10M-15.18M-72.78M-307.87M-584.69M-215.80M-133.73M-569.32M-652.65M-5.15B-947.67M-873.35M763.22M

Cash Flow

Currency: CNY2007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow37.14M2.54M42.71M-26.05M-31.74M5.23M-74.47M-68.92M-129.47M-36.50M-91.89M-104.17M-43.69M461.62M293.11M18.22B1.77B986.75M-166.80M
Investing Cash Flow1.66M-41.53M-54.39M-17.85M-48.53M-43.68M-60.58M-171.36M161.22M-570.34M182.14M-210.24M-32.66M-108.41M-357.22M-12.94B-4.19B-581.27M-
Financing Cash Flow15.40M-14.37M-165.96K570.83M-24.80M-24.67M97.13M-462.63K-17.17M1.23B-88.22M-103.38M-179.86M155.70M65.00M-275.82M-922.78M96.21M-
Capital Expenditure2.30M39.96M54.39M17.85M48.55M43.73M60.62M58.49M31.60M69.62M56.50M179.69M60.74M53.77M70.45M211.90M212.65M73.92M264.33M
Free Cash Flow34.84M-37.43M-11.68M-43.90M-80.28M-38.49M-135.09M-127.41M-161.07M-106.12M-148.39M-283.87M-104.44M407.85M222.67M18.01B1.56B912.83M-431.13M
Dividends Paid-11.12M65.96K-24.80M24.80M727.36K3.67M9.76M4.50M10.96M6.31M8.68M6.67M36.68M319.17M1.18B190.66M186.91M
FCF to OCF93.80%-1476.22%-27.36%168.53%252.97%-735.36%181.40%184.86%124.41%290.77%161.49%272.49%239.01%88.35%75.97%98.84%87.99%92.51%258.47%
Dividend Paid to FCF--29.72%-0.56%--30.89%-64.43%-0.54%-2.88%-6.06%-4.24%-7.38%-2.22%-8.32%1.64%16.47%1.77%75.60%20.89%-43.35%

Earnings

Report DateJun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Aug 16, 2016Oct 30, 2016Mar 1, 2017Apr 29, 2017Aug 24, 2017Oct 30, 2017Dec 31, 2017Apr 27, 2018Aug 28, 2018Oct 28, 2018Dec 31, 2018Apr 29, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Apr 29, 2020Aug 28, 2020Oct 29, 2020Dec 31, 2020Apr 28, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Apr 28, 2023Jun 30, 2023Oct 31, 2023Feb 23, 2024May 21, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Apr 28, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate--------------------------------------------------2.390.020.290.19-----------
EPS Actual0.040.020.010.000.030.020.010.000.010.01-0.010.000.010.00-0.040.00-0.02-0.060.11-0.05-0.06-0.07-0.23-0.04-0.07-0.130.26-0.04-0.07-0.09-0.18-0.06-0.05-0.040.17-0.08-0.03-0.070.340.110.490.24-0.280.080.04-0.011.8930.451.991.742.150.730.310.370.790.550.811.790.680.561.501.631.570.696.48
Surprise---------------------------------------------------10.04%3550.00%6.90%94.74%-----------
Timing------------------------Pre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-Pre-marketPre-marketPre-market-Pre-market---------------After-hours-After-hoursPre-marketAfter-hours---After-hours-----

Key Statistics & Ratios

Market Cap28.15B
Enterprise Value28.55B
Trailing P/E5.78
Forward P/E82.64
PEG Ratio0.00
Price / Sales24.88
Price / Book1.28
EPS10.44
Book Value55.16
Revenue (TTM)1.13B
Gross Profit (TTM)698.35M
EBITDA-247.92M
Profit Margin390.32%
Operating Margin-47.37%
Return on Equity19.50%
Return on Assets-0.54%
Shares Outstanding466.18M
Shares Float284.41M
Beta-0.62
Dividend Yield2.73%
Dividend Rate1.65
Payout Ratio15.92%

Dividends

20261×
1.65Jun 3, 2026
20251×
0.20Jun 11, 2025
20241×
0.30Jun 4, 2024
20231×
2.50Jun 13, 2023
20221×
0.70Jun 2, 2022
20211×
0.06Jun 3, 2021
20151×
0.02Jun 29, 2015
20121×
0.07May 23, 2012
20111×
0.07May 27, 2011

Stock Splits

  • May 31, 201315:10
  • May 27, 201120:10